Animal and human studies suggest that CRP may directly contribute to the inflammatory progression of atherosclerosis [32] via reducing the expression of nitric oxide synthase in endothelial cells [33] and significantly increasing expression levels of vascular cell adhesion molecules contributing to the atherosclerotic process [34]. The gene discussed is CRP; the disease is atherosclerosis.